Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/202585
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | GSE4 peptide suppresses oxidative and telomere deficiencies in Ataxia Telangiectasia patient cells |
Autor: | Pintado-Berninches, Laura CSIC ORCID ; Fernández-Varas, Beatriz CSIC; Benitez-Buelga, Carlos CSIC; Manguan-García, Cristina CSIC ORCID; Serrano-Benítez, Almudena CSIC; Iarriccio, Laura; Carrillo, Jaime CSIC; Guenechea, Guillermo; Egusquiaguirre, Susana P.; Pedraz, José Luís; Hernández, Rosa M.; Igartua, Manuela; Arias-Salgado, Elena G.; Cortés-Ledesma, Felipe CSIC ORCID; Sastre, Leandro CSIC ORCID; Perona Abellón, Rosario CSIC ORCID | Fecha de publicación: | 22-ene-2019 | Editor: | Nature Publishing Group | Citación: | Cell Death and Differentiation 26: 1998-2014 (2019) | Resumen: | Ataxia telangiectasia (AT) is a genetic disease caused by mutations in the ATM gene but the mechanisms underlying AT are not completely understood. Key functions of the ATM protein are to sense and regulate cellular redox status and to transduce DNA double-strand break signals to downstream effectors. ATM-deficient cells show increased ROS accumulation, activation of p38 protein kinase, and increased levels of DNA damage. GSE24.2 peptide and a short derivative GSE4 peptide corresponding to an internal domain of Dyskerin have proved to induce telomerase activity, decrease oxidative stress, and protect from DNA damage in dyskeratosis congenita (DC) cells. We have found that expression of GSE24.2 and GSE4 in human AT fibroblast is able to decrease DNA damage, detected by γ-H2A.X and 53BP1 foci. However, GSE24.2/GSE4 expression does not improve double-strand break signaling and repair caused by the lack of ATM activity. In contrast, they cause a decrease in 8-oxoguanine and OGG1-derived lesions, particularly at telomeres and mitochondrial DNA, as well as in reactive oxygen species, in parallel with increased expression of SOD1. These cells also showed lower levels of IL6 and decreased p38 phosphorylation, decreased senescence and increased ability to divide for longer times. Additionally, these cells are more resistant to treatment with H202 and the radiomimetic-drug bleomycin. Finally, we found shorter telomere length (TL) in AT cells, lower levels of TERT expression, and telomerase activity that were also partially reverted by GSE4. These observations suggest that GSE4 may be considered as a new therapy for the treatment of AT that counteracts the cellular effects of high ROS levels generated in AT cells and in addition increases telomerase activity contributing to increased cell proliferation. | Versión del editor: | http://dx.doi.org/10.1038/s41418-018-0272-7 | URI: | http://hdl.handle.net/10261/202585 | DOI: | 10.1038/s41418-018-0272-7 | Identificadores: | doi: 10.1038/s41418-018-0272-7 issn: 1350-9047 e-issn: 1476-5403 |
Aparece en las colecciones: | (CIB) Artículos (IIBM) Artículos (CABIMER) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
8
checked on 20-abr-2024
SCOPUSTM
Citations
19
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
14
checked on 27-feb-2024
Page view(s)
185
checked on 23-abr-2024
Download(s)
33
checked on 23-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.